Monocyte chemoattractant protein-1 in patients with peripheral arterial disease
Background: Chemokine-driven migration of inflammatory cells has been implicated in the pathogenesis of atherosclerotic conditions including peripheral arterial disease (PAD). Monocyte chemoattractant protein-1 (MCP-1) is elevated in patients with coronary artery disease and in hypertensive patients...
Saved in:
Main Authors: | Jana Petrkova (Author), Jaroslava Szotkowska (Author), Zuzana Hermanova (Author), Jan Lukl (Author), Martin Petrek (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2004-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Monocyte Chemoattractant Protein 1 is a Prognostic Marker in ANCA-Associated Small Vessel Vasculitis
by: Sophie Ohlsson, et al.
Published: (2009) -
Circulating Level of Monocyte Chemoattractant Protein-1 and Risk of Coronary Artery Disease: A Case–Control and Mendelian Randomization Study
by: Li J, et al.
Published: (2021) -
Assessment of serum levels of monocyte chemoattractant protein 1 (MCP 1) in patients with periodontitis and atherosclerotic cardiovascular disease
by: Safa A Hamad, et al.
Published: (2022) -
PARK2 mediates interleukin 6 and monocyte chemoattractant protein 1 production by human macrophages.
by: Louis de Léséleuc, et al.
Published: (2013) -
Elevated urinary monocyte chemoattractant protein-1 levels in children with Henoch-Schonlein purpura nephritis
by: Jiapei Wang, et al.
Published: (2018)